Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Sep;5(3):243-53.
doi: 10.2174/1874473711205030243.

Substance of abuse and movement disorders: complex interactions and comorbidities

Andres Deik  1 , Rachel Saunders-Pullman, Marta San Luciano
Affiliations
Review

Substance of abuse and movement disorders: complex interactions and comorbidities

Andres Deik et al. Curr Drug Abuse Rev. 2012 Sep.

Abstract

The relationship between movement disorders and substance abuse, which we previously reviewed, is updated. We examine these relationships bidirectionally with focus on drugs of abuse that are known to cause movement disorders, as well as primary movement disorders that are associated with use and abuse of alcohol and dopaminergic medications. First, we review the movement disorders that may develop from the acute use or withdrawal of frequent drugs of abuse, including alcohol, cocaine, heroin, amphetamine and methcathinone. We then comment on the interaction between alcoholism and alcohol-responsive movement disorders, such as essential tremor and myoclonus-dystonia. Lastly, we discuss the potential for abuse of antiparkinsonian dopaminergic agents in patients with Parkinson's disease (PD).

PubMed Disclaimer

References

    1. San Luciano M, Saunders-Pullman R. Substance abuse and movement disorders. Curr Drug Abuse Rev. 2009;2(3):273–278. - PubMed
    1. Dennison U, Clarkson M, O’Mullane J, Cassidy EM. The incidence and clinical correlates of lithium toxicity: a retrospective review. Ir J Med Sci. 2011;180(3):661–665. - PubMed
    1. Cazzola M, Matera MG. Tremor and beta(2)-adrenergic agents. Is it a real clinical problem? Pulm Pharmacol Ther. 2012;25(1):4–10. - PubMed
    1. Block F, Dafotakis M. Drug-induced tremor. Fortschr Neurol Psychiatr. 2011;79(10):570–575. - PubMed
    1. Clark GT. Medical management of oral motor disorders. dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions. J Calif Dent Assoc. 2006;34(8):657–667. - PubMed

Publication types

MeSH terms